CDK9-IN-19

SKU: orb1686552

Description

CDK9-IN-19 is a potent and selective CDK9 inhibitor (IC50 = 2.0 nM) with anti-proliferative activity in cancer cells. It demonstrates efficacy in MV4-11 xenograft models and is a research tool for studying acute myeloid leukemia (AML), offering moderate PK properties and low hERG liability.

Research Area

Cell Biology, Epigenetics & Chromatin

Key Properties

• CAS Number: 2479306-60-8
• MW: 508.47
• Formula: C₂₆H₂₂F₂N₄O₅
• SMILES: C(C)(=O)C1=C(C=2C(=CC(NC=3N=C(C(F)=CN3)C4=C(OC)C=C(F)C=C4)=CC2)OC1=O)N5CCOCC5
• Target: CDK,Others

Storage & Handling

• Storage: -20°C
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Compound Identifiers

PubChem CID

155677629